What is Cytek Biosciences, Inc.'s operating margin?

Cytek Biosciences, Inc. (CTKB) reported operating margin of -21.5% in Q1 2026.

What is the long-term trend for Cytek Biosciences, Inc.'s operating margin?

Over 4 years (2020 to 2025), Cytek Biosciences, Inc.'s operating margin has grown at a 6.7% compound annual growth rate (CAGR), from 15.5% to -20%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.

Cytek Biosciences, Inc. CTKB Operating margin

Operating margin at other companies

Becton, Dickinson and CompanyBDX

10.4%+0.1pp

Thermo Fisher ScientificTMO

17.2%+0.8pp

DanaherDHR

19.2%-1.0pp

Fulgent Genetics, Inc.FLGT

-33.1%+17.4pp

10x Genomics, Inc.TXG

-6.1%-2.7pp

TEC

Bio-TechneTECH

14.2%-7.9pp

Other financials

Income statement

See full

Revenue$44.1M+6.5%

Gross profit$21.3M+5.4%

Operating income-$18.5M-23.3%

Net income-$18.9M-65.5%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Cash & equivalents$31.8M-66.6%

Total debt$16.8M+40.9%

Total equity$327.6M-13.7%

Total assets$449.1M-6.9%

Cash flow

See full

Operating cash flow-$2.7M-2,089%

CapEx$2.2M+155%

Free cash flow-$4.9M-403%

Valuation

See full

Market cap$577.27M+54.5%

Enterprise value$562.23M+93.7%

P/S2.8×+0.9×

Profitability

See full

Gross margin51.7%-3.2pp

Net margin-36.2%—

FCF margin-6.2%-15.1pp

Returns & leverage

See full

Return on equity-20.9%—

Debt / equity0.1×0.0×

Current ratio4.7×-0.9×

Where this comes from

Calculated from Cytek Biosciences, Inc.’s reported figures.

operating income/total revenue=-21.5%

Based on trailing twelve months.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s operating margin?: Cytek Biosciences, Inc. (CTKB) reported operating margin of -21.5% in Q1 2026.
What is the long-term trend for Cytek Biosciences, Inc.'s operating margin?: Over 4 years (2020 to 2025), Cytek Biosciences, Inc.'s operating margin has grown at a 6.7% compound annual growth rate (CAGR), from 15.5% to -20%.
What does operating margin mean?: Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.